Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling.

BACKGROUND AND OBJECTIVES: Systematic reviews and economic modelling of clinical effectiveness and cost-effectiveness of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [using LISA-TRACKER(®) enzyme-linked immunosorbent assay (ELISA) kits (Theradiag, Marne La Vallee, France...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Technol Assess
Autors principals: Freeman, Karoline, Connock, Martin, Auguste, Peter, Taylor-Phillips, Sian, Mistry, Hema, Shyangdan, Deepson, Court, Rachel, Arasaradnam, Ramesh, Sutcliffe, Paul, Clarke, Aileen
Format: Artigo
Idioma:Inglês
Publicat: NIHR Journals Library 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124784/
https://ncbi.nlm.nih.gov/pubmed/27845027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta20830
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars